Global Jet Lag Treatment Market Growth (Status and Outlook) 2025-2031

Global Jet Lag Treatment Market Growth (Status and Outlook) 2025-2031

The global Jet Lag Treatment market size is predicted to grow from US$ 474 million in 2025 to US$ 612 million in 2031; it is expected to grow at a CAGR of 4.4% from 2025 to 2031.

Jet lag, also called jet lag disorder, is a temporary sleep problem that can affect anyone who quickly travels across multiple time zones. Jet lag can cause daytime fatigue, an unwell feeling, difficulty staying alert and gastrointestinal problems. Jet lag is temporary, but it can significantly reduce vacation or business travel comfort. Jet lag does not usually require treatment. Symptoms often improve within a few days, though they sometimes last longer. However, if you"re a frequent traveler continually bothered by jet lag, your doctor may prescribe medications.



The medication includes Nonbenzodiazepines, Benzodiazepines, Melatonin and some other drugs.



In our report, the measurement level is unit, which means that each unit is the same as each pill.

North America is the largest consumption place, with a consumption market share nearly 42%. Following North America, Europe is the second largest consumption place with the consumption market share of 23%.The key manufacturers are Teva, Mylan, Nature’s Bounty, Otsuka Pharma (Pharmavite), Boiron, Miers Laboratories, Genexa, Homeocan, Clinigen Group, Vanda Pharma etc. Top 3 companies occupied about 22% market share.

LPI (LP Information)' newest research report, the “Jet Lag Treatment Industry Forecast” looks at past sales and reviews total world Jet Lag Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Jet Lag Treatment sales for 2025 through 2031. With Jet Lag Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Jet Lag Treatment industry.

This Insight Report provides a comprehensive analysis of the global Jet Lag Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Jet Lag Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Jet Lag Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Jet Lag Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Jet Lag Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Jet Lag Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:
Prescription
OTC

Segmentation by Application:
Hospital Pharmacies
Retail Pharmacies
Online

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Teva
Mylan
Nature’s Bounty
Otsuka Pharma (Pharmavite)
Boiron
Miers Laboratories
Genexa
Homeocan
Clinigen Group
Vanda Pharma